Ketoacidosis associated with SGLT2 inhibitor treatment: Analysis of FAERS data

ConclusionsOur results support the FDA's warning that SGLT2 inhibitors lead to ketoacidosis, as evidenced by an increased reporting rate for acidosis above that in a comparator population treated with DPP4 inhibitors.

Source: Diabetes/Metabolism Research and Reviews - September 29, 2017 Category: Endocrinology Authors: Jenny E. Blau, Sri Harsha Tella, Simeon I. Taylor, Kristina I. Rother Tags: RESEARCH ARTICLE Source Type: research